)
Markets are likely to take cues from the Asian markets and weigh the Fed Reserve's decision to keep interest rates near zero for "considerable time".
Overseas investors bought Indian shares worth of 1.36 billion rupees ($22.3 million) on Wednesday.
The early indicator, SGX Nifty was trading at 7,957 levels down 33 points at 0830 hrs.
US stocks edged higher in volatile trading on Wednesday after the US Federal Reserve renewed its pledge to keep interest rates near zero for a "considerable time" and repeated concerns over slack in the labor market, standing firm against calls to overhaul its policy statement.
Interest rate projections, however, show Fed officials expect rate hikes, when they come, will do so at a quicker pace than previously forecast. The US dollar jumped against the euro and yen after the statement and data release.
Shares in financials, up 0.4 percent, extended gains to end the session as one of the better performing S&P sectors took the lead on the S&P 500.
Japanese shares jumped on Thursday after the dollar vaulted to a six-year peak on the yen as the Federal Reserve's outlook for rising rates underlined the diverging path between the United states and the rest of the rich world.
The euro skidded to a 14-month trough while gold hit an eight-month low as the dollar swept higher across the board, a move that many investors have been itching to wager on all year.
Indeed, the hawkish interpretation in currencies came despite the Fed maintaining language suggesting that rate hikes would not happen for a "considerable time."
STOCKS TO WATCH
In a bid to grab the opportunity created by diesel reaching market-parity price, Reliance Industries (RIL) has set the ball rolling on reopening its fuel retail outlets, after a gap of six years, and the company is in discussions with its dealers for a higher commission.
Mayank Pareek, the chief operating officer (marketing and sales) of Maruti Suzuki India (MSIL), has put in papers after nearly 20 years of service to pursue 'better opportunities', say sources familiar with the development.
Multi Commodity Exchange (MCX) has got a three-month conditional extension from the commodity markets regulator, Forward Markets Commission (FMC), to launch contracts till next March.
The US-based Merck & Co., Inc. and Sun Pharmaceuticals have entered into an exclusive worldwide licensing agreement for Merck's dermatology molecule - tildrakizumab (MK-3222), which is currently under phase 3 registration trials.
GVK's Australian partner Aurizon has decided to postpone its commitment to the coal mine development project till early next year thus delaying the project's timeline by two years as coal prices falling - making it unviable to mine coal in the near future.
